Zobrazeno 1 - 10
of 174
pro vyhledávání: '"Vibeke, Backer"'
Autor:
James Zangrilli, Liam G Heaney, Paul E Pfeffer, John Busby, Vibeke Backer, Takashi Iwanaga, Isha Chaudhry, Marjan Kerkhof, Celeste Porsbjerg, Enrico Heffler, Trung N. Tran, Mark Hew, Lakmini Bulathsinhala, Guy Brusselle, Marianna Alacqua, Todor A. Popov, Sverre Lehmann, Nikolaos G. Papadopoulos, Lauri Lehtimäki, Chris A. Price, Victoria Carter, Roland Buhl, Matthew J. Peters, Leif Bjermer, Alan Altraja, David A. Jackson, Yuji Tohda, Luis Pérez de Llano, Arnaud Bourdin, Chin Kook Rhee, Christian Taube, J. Mark FitzGerald, Mariko Siyue Koh, Unnur S. Bjornsdottir, Neva Eleangovan, Giorgio Walter Canonica, Andriana I. Papaioannou, David Price, Naeimeh Hosseini, Camille Taillé, Borja G. Cosío, Michael E. Wechsler, Mona Al-Ahmad, Mohsen Sadatsafavi, Andrew Menzies-Gow, Ruth Murray, George Christoff, Richard W. Costello, Eileen Wang
Publikováno v:
Chest. 160:814-830
Background Phenotypic characteristics of patients with eosinophilic and noneosinophilic asthma are not well characterized in global, real-life severe asthma cohorts. Research Question What is the prevalence of eosinophilic and noneosinophilic phenoty
Publikováno v:
Obling, N, Backer, V, Hurst, J R & Bodtger, U 2021, ' Upper airway symptoms associate with the eosinophilic phenotype of copd ', ERJ Open Research, vol. 7, no. 3, 00184-2021 . https://doi.org/10.1183/23120541.00184-2021
ERJ Open Research
article-version (VoR) Version of Record
ERJ Open Research, Vol 7, Iss 3 (2021)
ERJ Open Research
article-version (VoR) Version of Record
ERJ Open Research, Vol 7, Iss 3 (2021)
Background There is growing evidence that upper airway symptoms coexist with lower airway symptoms in COPD. Still, the prevalence and impact of upper airway disease on the nature and course of COPD remain unclear. We aimed to describe this in a cross
Autor:
Vibeke Backer, Celeste Porsbjerg, Jesper Østrup Nielsen, Morten Hvidtfeldt, Alexander Silberbrandt, Laurits Frøssing, Thomas Hartvig Lindkær Jensen, Deborah Parker
Publikováno v:
Journal of Asthma. 59:552-560
Cell differential count (CDC) of induced sputum is considered the gold standard for inflammatory phenotyping of asthma but is not implemented in routine care due to its heavy time- and staff demands. Digital Cell Morphology is a technique where digit
Autor:
Casper Tidemandsen, Anne Vejen Hansen, Zarqa Ali, Elisabeth Juul Gade, Charlotte Suppli Ulrik, Vibeke Backer
Publikováno v:
Journal of Asthma and Allergy. 13:145-152
Background Asthma has been linked with prolonged time to pregnancy compared to healthy controls, also asthma has been linked to a higher need for fertility treatment. However, knowledge of the possible association between allergy and need for fertili
Autor:
Erik Sören Halvard Hansen, Nikolaj Brix Hansen, Søren Malte Rasmussen, Vibeke Backer, Louise Lindhart Toennesen, Anders Pitzner-Fabricius
Publikováno v:
Journal of Physical Medicine and Rehabilitation. 2:14-17
Autor:
Vibeke Backer, Jens Bangsbo, Sajad Habib, Anders Krogh Lemminger, Søren Jessen, Stella Feng Sheng Xu, Johan Onslev, Morten Hostrup
Publikováno v:
Scandinavian Journal of Medicine & Science in Sports. 29:1881-1891
While beta2 -adrenoceptor stimulation has been shown to increase lean mass and to alter metabolic properties of skeletal muscle, adaptations in muscle oxidative enzymes and maximal oxygen uptake ( V˙ O2max ) in response to beta2 -adrenergic agonist
Publikováno v:
Monitoring airway disease.
Autor:
Marcin Kurowski, Sergio Bonini, Pekka Malmberg, Katja Radon, Sofia Vakali, Søren Malte Rasmussen, Trine Stensrud, Luís Delgado, Nikos Papadoupolous, Erik Sören Halvard Hansen, Marek L. Kowalski, Tari Haahtela, Mikko Voutilainen, André Moreira, Franchek Drobnik, Christina Gratziou, Matteo Bonini, Vibeke Backer, Jean Bousquet
Publikováno v:
Epidemiology.
Autor:
Martin R. Miller, Vibeke Backer, Simon Francis Thomsen, Torben Sigsgaard, Jacob v. B. Hjelmborg, Howraman Meteran
Publikováno v:
Meteran, H, Thomsen, S F, Miller, M R, Hjelmborg, J, Sigsgaard, T & Backer, V 2021, ' Impact of the spirometric definition on comorbidities in chronic obstructive pulmonary disease ', Respiratory Medicine, vol. 184, 106399 . https://doi.org/10.1016/j.rmed.2021.106399
Background: Little is known about how the spirometric definition of airway obstruction affects the association between COPD and comorbidities and whether these associations might be due to genetic predisposition.Aim: 1) To examine the impact of the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cda80c7b7a60baeee766ea3960053bf
https://pure.au.dk/portal/da/publications/impact-of-the-spirometric-definition-on-comorbidities-in-chronic-obstructive-pulmonary-disease(36320ae7-1a4b-4844-958b-f6692c411f33).html
https://pure.au.dk/portal/da/publications/impact-of-the-spirometric-definition-on-comorbidities-in-chronic-obstructive-pulmonary-disease(36320ae7-1a4b-4844-958b-f6692c411f33).html
Autor:
David P. Sonne, Jesper Sonne, Victoria Becker, Torben Balchen, Vibeke Backer, Mads Jellingsø, Anne Weiss, Morten Hostrup, Ulf Sjöbring, Helle Krogh Johansen, Morten Otto Alexander Sommer
Publikováno v:
The Lancet Regional Health. Europe, Vol 4, Iss, Pp 100084-(2021)
Backer, V, Sjöbring, U, Sonne, J, Weiss, A, Hostrup, M, Johansen, H K, Becker, V, Sonne, D P, Balchen, T, Jellingsø, M & Sommer, M O A 2021, ' A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19 ', Lancet Regional Health. Europe, vol. 4, 100084 . https://doi.org/10.1016/j.lanepe.2021.100084
The Lancet Regional Health. Europe
Backer, V, Sjöbring, U, Sonne, J, Weiss, A, Hostrup, M, Johansen, H K, Becker, V, Sonne, D P, Balchen, T, Jellingsø, M & Sommer, M O A 2021, ' A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19 ', The Lancet Regional Health-Europe, vol. 4, 100084 . https://doi.org/10.1016/j.lanepe.2021.100084
Backer, V, Sjöbring, U, Sonne, J, Weiss, A, Hostrup, M, Johansen, H K, Becker, V, Sonne, D P, Balchen, T, Jellingsø, M & Sommer, M O A 2021, ' A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19 ', Lancet Regional Health. Europe, vol. 4, 100084 . https://doi.org/10.1016/j.lanepe.2021.100084
The Lancet Regional Health. Europe
Backer, V, Sjöbring, U, Sonne, J, Weiss, A, Hostrup, M, Johansen, H K, Becker, V, Sonne, D P, Balchen, T, Jellingsø, M & Sommer, M O A 2021, ' A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19 ', The Lancet Regional Health-Europe, vol. 4, 100084 . https://doi.org/10.1016/j.lanepe.2021.100084
Background: Coronavirus disease 19 (COVID-19) is spreading globally and treatment options remain limited. A formulation of niclosamide, a potent anti-SARS-CoV-2 agent and a broad-spectrum antiviral treatment candidate, optimized for inhalation and in